Interwest Venture Management CO has filed its 13F form on October 20, 2023 for Q3 2023 where it was disclosed a total value porftolio of $20.6 Million distributed in 5 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pmv Pharmaceuticals, Inc. with a value of $9.92M, The Real Real, Inc. with a value of $4.97M, Sera Prognostics, Inc. with a value of $4.49M, Glaukos Corp with a value of $1.23M, and Dare Bioscience, Inc. with a value of $28K.

Examining the 13F form we can see an decrease of $3.87M in the current position value, from $24.5M to 20.6M.

Below you can find more details about Interwest Venture Management CO portfolio as well as his latest detailed transactions.

Portfolio value $20.6 Million
Healthcare: $15.7 Million
Consumer Cyclical: $4.97 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 5
  • Current Value $20.6 Million
  • Prior Value $24.5 Million
  • Filing
  • Period Q3 2023
  • Filing Date October 20, 2023
  • Form Type 13F-HR
  • Activity in Q3 2023
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Interwest Venture Management CO Portfolio

Follow Interwest Venture Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Interwest Venture Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Interwest Venture Management CO with notifications on news.